Acotec (先瑞达) IPO: Risk-Reward Does Not Warrant Participation
We look at the deal term and are of the view that the risk reward does not warrant a participation on Acotec at the high end.
477 Views
ECM Weekly (1st August 2021) - Cloud Village, Li Auto HK, Asymchem, Acotec, Devyani, Del Monte PH
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
533 Views
Acotec (先瑞达) Pre-IPO: Thoughts on Valuation
We provide our forecast and valuation for the company's two key products AcoArt Orchid & Dhalia, as well as AcoArt Tulip & Litos.
365 Views
Shanghai HeartCare (心玮医疗) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
638 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
795 Views